Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 4 results out of 4

Company Profiles

Access comprehensive reports covering all the major players in the pharmaceutical industry

Buy Now

Data Insights

OR-502 is under clinical development by OncoResponse and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...

Data Insights

OR-502 is under clinical development by OncoResponse and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs...

Data Insights

OR-502 is under clinical development by OncoResponse and currently in Phase II for Sarcomas. According to GlobalData, Phase II drugs...

Data Insights

OR-502 is under clinical development by OncoResponse and currently in Phase II for Cutaneous Squamous Cell Carcinoma (cSCC). According to...